Combined vitamin D, ibuprofen and glutamic acid decarboxylase-alum treatment in recent onset Type I diabetes: lessons from the DIABGAD randomized pilot trial

Johnny Ludvigsson,Indusmita Routray,Sriramulu Elluru,Per Leanderson,Helena Elding-Larsson,Björn Rathsman,Ragnar Hanas,Annelie Carlsson,Torben Ek,Ulf Samuelsson,Torun Torbjörnsdotter,Jan Åman,Eva Örtqvist,Karun Badwal,Craig A. Beam,Rosaura Casas

Combined vitamin D, ibuprofen and glutamic acid decarboxylase-alum treatment in recent onset Type I diabetes: lessons from the DIABGAD randomized pilot trial

2020

Johnny Ludvigsson
Indusmita Routray
Sriramulu Elluru
Per Leanderson
Helena Elding-Larsson
Björn Rathsman
Ragnar Hanas
Annelie Carlsson
Torben Ek
Ulf Samuelsson
Torun Torbjörnsdotter
Jan Åman
Eva Örtqvist
Karun Badwal
Craig A. Beam
Rosaura Casas

Aim: Double-blind placebo-controlled intervention using glutamic acid decarboxylase (GAD)-alum, vitamin D and Ibuprofen in recent onset Type I diabetes (T1D). Methods: 64 patients (T1D since <4 mon...

Keywords:

C-peptide
Pharmacology
Immune system
Diabetes mellitus
Medicine
Vitamin D and neurology
Glutamate decarboxylase
Ibuprofen
Immunology
Alum
type i diabetes

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations